GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syntara Ltd (OTCPK:PMXSF) » Definitions » FCF Yield %

Syntara (Syntara) FCF Yield % : -58.37 (As of May. 07, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Syntara FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Syntara's Trailing 12-Month Free Cash Flow is $-7.48 Mil, and Market Cap is $18.18 Mil. Therefore, Syntara's FCF Yield % for today is -58.37%.

The historical rank and industry rank for Syntara's FCF Yield % or its related term are showing as below:

PMXSF' s FCF Yield % Range Over the Past 10 Years
Min: -194.15   Med: -27.24   Max: 32.95
Current: -58.37


During the past 13 years, the highest FCF Yield % of Syntara was 32.95%. The lowest was -194.15%. And the median was -27.24%.

PMXSF's FCF Yield % is ranked worse than
91.59% of 1082 companies
in the Drug Manufacturers industry
Industry Median: -0.64 vs PMXSF: -58.37

Syntara's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.


Syntara FCF Yield % Historical Data

The historical data trend for Syntara's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syntara FCF Yield % Chart

Syntara Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.96 -25.47 5.22 -32.31 -26.60

Syntara Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.10 -40.95 -6.76 -45.20 -30.07

Competitive Comparison of Syntara's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Syntara's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syntara's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syntara's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Syntara's FCF Yield % falls into.



Syntara FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Syntara's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-4.977 / 18.709184
=-26.60%

Syntara's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-3.248 * 2 / 21.606156
=-30.07%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syntara FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Syntara FCF Yield % Related Terms

Thank you for viewing the detailed overview of Syntara's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Syntara (Syntara) Business Description

Traded in Other Exchanges
Address
20 Rodborough Road, Locked Bag 5015, Frenchs Forest, Sydney, NSW, AUS, 2086
Syntara Ltd Formerly Pharmaxis Ltd is an Australia based pharmaceutical research company engaged in the research, development, and commercialization of human healthcare products for the treatment and management of fibrotic and inflammatory diseases. The firm's research efforts are focused on discovering drugs to treat inflammatory and fibrotic diseases such as NASH, pulmonary fibrosis, kidney and liver fibrosis and cancer from its amine oxidase inhibitor chemistry platform. Its product pipeline also includes Orbital and ASM8. The operating segments are Mannitol respiratory business and New Drug Development. It generates maximum revenue from Mannitol respiratory business segment.

Syntara (Syntara) Headlines